Table of Contents Global Retinal Drugs and Biologics Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Retinal Drugs and Biologics Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Retinal Drugs and Biologics Segment by Type 1.2.1 Age Related Macular Degeneration 1.2.2 Diabetic Retinopathy 1.2.3 Ocular Inflammatory Disease (Uveitis) 1.2.4 Macular Hole 1.3 Market Analysis by Application 1.3.1 Hospitals 1.3.2 Clinics 1.3.3 Others 1.4 Overview of Global Retinal Drugs and Biologics Market 1.4.1 Global Retinal Drugs and Biologics Revenue (2015-2025) 1.4.2 Global Retinal Drugs and Biologics Production and Capacity (2015-2025) 1.4.3 North America Retinal Drugs and Biologics Status and Prospect (2015-2025) 1.4.4 Europe Retinal Drugs and Biologics Status and Prospect (2015-2025) 1.4.5 Japan Retinal Drugs and Biologics Status and Prospect (2014-2025) 1.4.6 China Retinal Drugs and Biologics Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Retinal Drugs and Biologics Industry Impact 1.6.1 How the Covid-19 is Affecting the Retinal Drugs and Biologics Industry 1.6.2 Retinal Drugs and Biologics Business Impact Assessment - Covid-19 1.6.3 Market Trends and Retinal Drugs and Biologics Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Retinal Drugs and Biologics Market Competition by Manufacturer 2.1 Global Retinal Drugs and Biologics Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Retinal Drugs and Biologics Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Retinal Drugs and Biologics Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Retinal Drugs and Biologics Manufacturer Market Share 2.5 Top 10 Retinal Drugs and Biologics Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Retinal Drugs and Biologics Market 2.7 Key Manufacturers Retinal Drugs and Biologics Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Retinal Drugs and Biologics Industry Key Manufacturers 3.1 ALLERGAN 3.1.1 Company Details 3.1.2 Product Information 3.1.3 ALLERGAN Retinal Drugs and Biologics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 ALLERGAN News 3.2 AbbVie 3.2.1 Company Details 3.2.2 Product Information 3.2.3 AbbVie Retinal Drugs and Biologics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 AbbVie News 3.3 Alimera Sciences 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Alimera Sciences Retinal Drugs and Biologics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Alimera Sciences News 3.4 Janssen Biotech 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Janssen Biotech Retinal Drugs and Biologics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Janssen Biotech News 3.5 Swedish Orphan Biovitrum 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Swedish Orphan Biovitrum News 3.6 Roche 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Roche Retinal Drugs and Biologics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Roche News 3.7 Bristol-Myers Squibb 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Bristol-Myers Squibb Retinal Drugs and Biologics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Bristol-Myers Squibb News 3.8 Genzyme 3.8.1 Company Details 3.8.2 Product Information 3.8.3 Genzyme Retinal Drugs and Biologics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 Genzyme News 3.9 Genentech 3.9.1 Company Details 3.9.2 Product Information 3.9.3 Genentech Retinal Drugs and Biologics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.9.4 Main Business Overview 3.9.5 Genentech News 3.10 OCULAR THERAPEUTIX 3.10.1 Company Details 3.10.2 Product Information 3.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.10.4 Main Business Overview 3.10.5 OCULAR THERAPEUTIX News 3.11 Bausch & Lomb 3.11.1 Company Details 3.11.2 Product Information 3.11.3 Bausch & Lomb Retinal Drugs and Biologics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.11.4 Main Business Overview 3.11.5 Bausch & Lomb News 3.12 UCBCares 3.12.1 Company Details 3.12.2 Product Information 3.12.3 UCBCares Retinal Drugs and Biologics Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.12.4 Main Business Overview 3.12.5 UCBCares News 4 Global Retinal Drugs and Biologics Market Size Categorized by Regions (2015-2020) 4.1 Global Retinal Drugs and Biologics Sales Market Share by Region 4.2 Global Retinal Drugs and Biologics Revenue Market Share by Region (2015-2019) 4.3 Global Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Retinal Drugs and Biologics Market Size Detail 4.4.1 North America Retinal Drugs and Biologics Sales Growth Rate (2015-2020) 4.4.2 North America Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Retinal Drugs and Biologics Market Size Detail 4.5.1 Europe Retinal Drugs and Biologics Sales Growth Rate (2015-2020) 4.5.2 Europe Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Retinal Drugs and Biologics Market Size Detail 4.6.1 Japan Retinal Drugs and Biologics Sales Growth Rate (2015-2020) 4.6.2 Japan Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Retinal Drugs and Biologics Market Size Detail 4.7.1 China Retinal Drugs and Biologics Sales Growth Rate (2015-2020) 4.7.2 China Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Retinal Drugs and Biologics Market Segment by Type 5.1 Global Retinal Drugs and Biologics Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Retinal Drugs and Biologics Sales and Market Share by Type (2015-2020) 5.1.2 Global Retinal Drugs and Biologics Revenue and Market Share by Type (2015-2020) 5.2 Age Related Macular Degeneration Sales Growth Rate and Price 5.2.1 Global Age Related Macular Degeneration Sales Growth Rate (2015-2020) 5.2.2 Global Age Related Macular Degeneration Price (2015-2020) 5.3 Diabetic Retinopathy Sales Growth Rate and Price 5.3.1 Global Diabetic Retinopathy Sales Growth Rate (2015-2020) 5.3.2 Global Diabetic Retinopathy Price (2015-2020) 5.4 Ocular Inflammatory Disease (Uveitis) Sales Growth Rate and Price 5.4.1 Global Ocular Inflammatory Disease (Uveitis) Sales Growth Rate (2015-2020) 5.4.2 Global Ocular Inflammatory Disease (Uveitis) Price (2015-2020) 5.5 Macular Hole Sales Growth Rate and Price 5.5.1 Global Macular Hole Sales Growth Rate (2015-2020) 5.5.2 Global Macular Hole Price (2015-2020) 6 Global Retinal Drugs and Biologics Market Segment by Application 6.1 Global Retinal Drugs and Biologics Sales Market Share by Application (2015-2020) 6.2 Hospitals Sales Growth Rate (2015-2020) 6.3 Clinics Sales Growth Rate (2015-2020) 6.4 Others Sales Growth Rate (2015-2020) 7 Retinal Drugs and Biologics Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Retinal Drugs and Biologics Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Retinal Drugs and Biologics Market Forecast 8.1 Global Retinal Drugs and Biologics Sales, Revenue Forecast 8.1.1 Global Retinal Drugs and Biologics Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Retinal Drugs and Biologics Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Retinal Drugs and Biologics Price and Trend Forecast (2020-2025) 8.2 Global Retinal Drugs and Biologics Sales Forecast by Region (2020-2025) 8.2.1 North America Retinal Drugs and Biologics Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Retinal Drugs and Biologics Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Retinal Drugs and Biologics Production, Revenue Forecast (2020-2025) 8.2.4 China Retinal Drugs and Biologics Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Retinal Drugs and Biologics Picture Table Global Retinal Drugs and Biologics Sales by Type Figure Global Sales Market Share of Retinal Drugs and Biologics by Product Type in 2019 Table Breakdown of Retinal Drugs and Biologics by Company Type (Tier 1, Tier 2 and Tier 3) Figure Retinal Drugs and Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Age Related Macular Degeneration Picture Figure Diabetic Retinopathy Picture Figure Ocular Inflammatory Disease (Uveitis) Picture Figure Macular Hole Picture Table Global Retinal Drugs and Biologics Sales by Application Figure Global Retinal Drugs and Biologics Sales Market Share by Application in 2019 Figure Hospitals Picture Figure Clinics Picture Figure Others Picture Table Retinal Drugs and Biologics Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Retinal Drugs and Biologics Revenue (Million US$) (2015-2025) Figure Global Retinal Drugs and Biologics Production (K Units) (2015-2025) Figure North America Retinal Drugs and Biologics Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Retinal Drugs and Biologics Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Retinal Drugs and Biologics Revenue (Million US$) Growth Rate (2014-2025) Figure China Retinal Drugs and Biologics Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Retinal Drugs and Biologics Sales by Manufacturer (2018-2020) Figure Global Retinal Drugs and Biologics Sales Market Share by Manufacturer in 2019 Table Global Retinal Drugs and Biologics Revenue by Manufacturer (2018-2020) Figure Global Retinal Drugs and Biologics Revenue Market Share by Manufacturer in 2019 Table Global Retinal Drugs and Biologics Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Retinal Drugs and Biologics Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Retinal Drugs and Biologics Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Retinal Drugs and Biologics Market Table Key Manufacturers Retinal Drugs and Biologics Product Type Table Mergers & Acquisitions Planning Table ALLERGAN Company Profile Figure Retinal Drugs and Biologics Product Picture and Specifications of ALLERGAN Table Retinal Drugs and Biologics Production, Price, Revenue and Gross Margin of 2018-2020 Figure ALLERGAN Retinal Drugs and Biologics Market Share (2018-2020) Table ALLERGAN Main Business Table ALLERGAN Recent Development Table AbbVie Company Profile Figure Retinal Drugs and Biologics Product Picture and Specifications of AbbVie Table Retinal Drugs and Biologics Production, Price, Revenue and Gross Margin of 2018-2020 Figure AbbVie Retinal Drugs and Biologics Market Share (2018-2020) Table AbbVie Main Business Table AbbVie Recent Development Table Alimera Sciences Company Profile Figure Retinal Drugs and Biologics Product Picture and Specifications of Alimera Sciences Table Retinal Drugs and Biologics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Alimera Sciences Retinal Drugs and Biologics Market Share (2018-2020) Table Alimera Sciences Main Business Table Alimera Sciences Recent Development Table Janssen Biotech Company Profile Figure Retinal Drugs and Biologics Product Picture and Specifications of Janssen Biotech Table Retinal Drugs and Biologics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Janssen Biotech Retinal Drugs and Biologics Market Share (2018-2020) Table Janssen Biotech Main Business Table Janssen Biotech Recent Development Table Swedish Orphan Biovitrum Company Profile Figure Retinal Drugs and Biologics Product Picture and Specifications of Swedish Orphan Biovitrum Table Retinal Drugs and Biologics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Market Share (2018-2020) Table Swedish Orphan Biovitrum Main Business Table Swedish Orphan Biovitrum Recent Development Table Roche Company Profile Figure Retinal Drugs and Biologics Product Picture and Specifications of Roche Table Retinal Drugs and Biologics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Roche Retinal Drugs and Biologics Market Share (2018-2020) Table Roche Main Business Table Roche Recent Development Table Bristol-Myers Squibb Company Profile Figure Retinal Drugs and Biologics Product Picture and Specifications of Bristol-Myers Squibb Table Retinal Drugs and Biologics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bristol-Myers Squibb Retinal Drugs and Biologics Market Share (2018-2020) Table Bristol-Myers Squibb Main Business Table Bristol-Myers Squibb Recent Development Table Genzyme Company Profile Figure Retinal Drugs and Biologics Product Picture and Specifications of Genzyme Table Retinal Drugs and Biologics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Genzyme Retinal Drugs and Biologics Market Share (2018-2020) Table Genzyme Main Business Table Genzyme Recent Development Table Genentech Company Profile Figure Retinal Drugs and Biologics Product Picture and Specifications of Genentech Table Retinal Drugs and Biologics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Genentech Retinal Drugs and Biologics Market Share (2018-2020) Table Genentech Main Business Table Genentech Recent Development Table OCULAR THERAPEUTIX Company Profile Figure Retinal Drugs and Biologics Product Picture and Specifications of OCULAR THERAPEUTIX Table Retinal Drugs and Biologics Production, Price, Revenue and Gross Margin of 2018-2020 Figure OCULAR THERAPEUTIX Retinal Drugs and Biologics Market Share (2018-2020) Table OCULAR THERAPEUTIX Main Business Table OCULAR THERAPEUTIX Recent Development Table Bausch & Lomb Company Profile Figure Retinal Drugs and Biologics Product Picture and Specifications of Bausch & Lomb Table Retinal Drugs and Biologics Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bausch & Lomb Retinal Drugs and Biologics Market Share (2018-2020) Table Bausch & Lomb Main Business Table Bausch & Lomb Recent Development Table UCBCares Company Profile Figure Retinal Drugs and Biologics Product Picture and Specifications of UCBCares Table Retinal Drugs and Biologics Production, Price, Revenue and Gross Margin of 2018-2020 Figure UCBCares Retinal Drugs and Biologics Market Share (2018-2020) Table UCBCares Main Business Table UCBCares Recent Development Table Global Retinal Drugs and Biologics Sales (K Units) by Region (2015-2020) Table Global Retinal Drugs and Biologics Sales Market Share by Region (2015-2019) Figure Global Retinal Drugs and Biologics Sales Market Share by Region (2015-2019) Figure Global Retinal Drugs and Biologics Sales Market Share by Region in 2018 Table Global Retinal Drugs and Biologics Revenue (Million US$) by Region (2015-2020) Table Global Retinal Drugs and Biologics Revenue Market Share by Region (2015-2020) Figure Global Retinal Drugs and Biologics Revenue Market Share by Region (2015-2020) Figure Global Retinal Drugs and Biologics Revenue Market Share by Region in 2019 Table Global Retinal Drugs and Biologics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Retinal Drugs and Biologics Sales (K Units) Growth Rate (2015-2020) Figure Europe Retinal Drugs and Biologics Sales (K Units) Growth Rate (2015-2020) Table Europe Retinal Drugs and Biologics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Retinal Drugs and Biologics Sales (K Units) Growth Rate (2015-2020) Table Japan Retinal Drugs and Biologics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Retinal Drugs and Biologics Sales (K Units) Growth Rate (2015-2020) Table China Retinal Drugs and Biologics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Retinal Drugs and Biologics Sales by Type (2015-2020) Table Global Retinal Drugs and Biologics Sales Market Share by Type (2015-2020) Figure Global Retinal Drugs and Biologics Sales Market Share by Type in 2019 Table Global Retinal Drugs and Biologics Revenue by Type (2015-2020) Table Global Retinal Drugs and Biologics Revenue Market Share by Type (2015-2020) Figure Global Retinal Drugs and Biologics Revenue Market Share by Type in 2019 Figure Global Age Related Macular Degeneration Sales Growth Rate (2015-2025) Figure Global Age Related Macular Degeneration Price (2015-2020) Figure Global Diabetic Retinopathy Sales Growth Rate (2015-2025) Figure Global Diabetic Retinopathy Price (2015-2020) Figure Global Ocular Inflammatory Disease (Uveitis) Sales Growth Rate (2015-2025) Figure Global Ocular Inflammatory Disease (Uveitis) Price (2015-2020) Figure Global Macular Hole Sales Growth Rate (2015-2025) Figure Global Macular Hole Price (2015-2020) Table Global Retinal Drugs and Biologics Sales Market Share by Application (2015-2020) Figure Global Retinal Drugs and Biologics Sales Market Share by Application in 2019 Figure Global Hospitals Sales Growth Rate (2015-2025) Figure Global Clinics Sales Growth Rate (2015-2025) Figure Global Others Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Retinal Drugs and Biologics Table Key Players of Downstream Markets Figure Sales Channel Figure Global Retinal Drugs and Biologics Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Retinal Drugs and Biologics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Retinal Drugs and Biologics Price and Trend Forecast (2020-2025) Table Global Retinal Drugs and Biologics Sales (K Units) Forecast by Region (2020-2025) Figure Global Retinal Drugs and Biologics Production Market Share Forecast by Region (2020-2025) Figure North America Retinal Drugs and Biologics Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Retinal Drugs and Biologics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Retinal Drugs and Biologics Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Retinal Drugs and Biologics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Retinal Drugs and Biologics Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Retinal Drugs and Biologics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Retinal Drugs and Biologics Production (K Units) Growth Rate Forecast (2020-2025) Figure China Retinal Drugs and Biologics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

ALLERGAN AbbVie Alimera Sciences Janssen Biotech Swedish Orphan Biovitrum Roche Bristol-Myers Squibb Genzyme Genentech OCULAR THERAPEUTIX